Targeted News Service logo

-- Preview Email Newsletter
Research in Professional Journals Newsletter for 2025-11-10 ( 23 items )  
Ablation reduces stroke risk for AFib and may remove need for some types of blood thinners (10)
DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release: * * * Ablation reduces stroke risk for AFib and may remove need for some types of blood thinners * Research Highlights: * Successful catheter ablation resulted in a low risk of stroke associated with atrial fibrillation (AFib), a type of irregular heart rhythm, according to an international study. * Researchers said these findings may suggest that ongoing blood-thinning me more PR

Big Data Before Data Science: Series A Seeks Submissions for Special Journal Issue (10)
LONDON, England, Nov. 9 -- The Royal Statistical Society issued the following news: * * * Big Data before Data Science: Series A seeks submissions for special journal issue The editors of the Journal of the Royal Statistical Society, Series A are seeking submissions for an upcoming special edition: 'Big Data before Data Science: legacies from the collection, analysis, and communication of large-scale human data from an era of paper tools'. This special issue is inspired by the December 2025 more PR

Chance to win cash doubled medication use, yet led to similar blood pressure reductions (10)
DALLAS, Texas, Nov. 9 [Category: Health Care] -- The American Heart Association posted the following news release: * * * Chance to win cash doubled medication use, yet led to similar blood pressure reductions * Research Highlights: * A study of 400 adults with high blood pressure found that participants were twice as likely to take their blood pressure medication (measured by electronic pill bottles that recorded when bottles were opened) when they could win a daily cash reward compared t more PR

Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely Lower Cholesterol and Triglycerides (10)
CLEVELAND, Ohio, Nov. 8 [Category: BizHospital] -- The Cleveland Clinic posted the following news release: * * * Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely Lower Cholesterol and Triglycerides * Results from a Cleveland Clinic Phase 1, first-in-human clinical trial showed that a one-time infusion of a gene-editing therapy using CRISPR-Cas9 safely reduced LDL ("bad") cholesterol and triglycerides in people with lipid disorders resistant to current medi more PR

Cup of coffee a day may not be harmful for some adults with AFib and could lower episodes (10)
DALLAS, Texas, Nov. 9 [Category: Health Care] -- The American Heart Association posted the following news release: * * * Cup of coffee a day may not be harmful for some adults with AFib and could lower episodes * Research Highlights: * During the 6 months after treatment to restore a normal heart rhythm, adults with atrial fibrillation (AFib) who were randomly assigned to drink coffee every day were 39% less likely to have a recurrence of AFib compared to participants assigned to not have more PR

Diabetes drug reduced irregular heartbeat events in overweight/obese adults with AFib (10)
DALLAS, Texas, Nov. 9 [Category: Health Care] -- The American Heart Association posted the following news release: * * * Diabetes drug reduced irregular heartbeat events in overweight/obese adults with AFib * Research Highlights: * Adults with atrial fibrillation and obesity/overweight (but no diabetes) who took the diabetes medication metformin after a rhythm correction procedure were more likely to stay free of AFib episodes for a year. * Weight loss was not thought to be the main re more PR

Earlier blood transfusion may reduce heart failure, arrhythmia in adults with heart disease (10)
DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release: * * * Earlier blood transfusion may reduce heart failure, arrhythmia in adults with heart disease * Research Highlights: * Earlier blood transfusion after major surgery - when hemoglobin was below 10 g/dL rather than beow 7 g/dl - did not affect the risk of severe complications, such as death, heart attack, need for a heart procedure, kidney failure or stroke. * However, t more PR

First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides (10)
DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release: * * * First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides * Research Highlights: * In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and reduced triglycerides by about 55%. * Cholesterol more PR

For Black adults in food deserts, food delivery & dietary guidance reduced blood pressure (10)
DALLAS, Texas, Nov. 9 [Category: Health Care] -- The American Heart Association posted the following news release: * * * For Black adults in food deserts, food delivery & dietary guidance reduced blood pressure * Research Highlights: * A grocery support program based on the low-sodium DASH eating plan that included home-delivered groceries and dietary counseling reduced blood pressure levels in Black adults living in areas where grocery stores were inaccessible or scarce, known as food de more PR

Heart attack risk halved in adults with heart disease taking tailored vitamin D doses (10)
DALLAS, Texas, Nov. 9 [Category: Health Care] -- The American Heart Association posted the following news release: * * * Heart attack risk halved in adults with heart disease taking tailored vitamin D doses * Research Highlights: * Adults with heart disease prescribed vitamin D in doses tailored to reach blood levels considered optimal for heart health (>40-80 ng/mL) had a reduced risk of heart attack by more than half (52%) compared to those who did not receive monitoring of vitamin D le more PR

Helmholtz Centre for Environmental Research: Plant Protection Products Change the Behaviour of Non-Target Organisms (10)
LEIPZIG, Germany, Nov. 8 -- The Helmholtz Centre for Environmental Research issued the following news release on Nov. 7, 2025: * * * Plant protection products change the behaviour of non-target organisms UFZ team demonstrates effects on pollinators and fish * Plant protection products protect crops from pests, diseases and weeds. However, many of the fungicides, herbicides and insecticides also have a negative effect on terrestrial and aquatic organisms such as pollinators or fish that are  more PR

Institute of Cancer Research: New Combination Treatment Could Overcome Immunotherapy Resistance in Difficult-To-Treat Cancers (10)
LONDON, England, Nov. 8 -- The Institute of Cancer Research issued the following news on Nov. 7, 2025: * * * New combination treatment could overcome immunotherapy resistance in difficult-to-treat cancers A pioneering clinical trial has demonstrated for the first time that two existing treatments can be combined to potentially improve outcomes for sarcoma and melanoma patients with advanced tumours in their limbs. The researchers delivered a specific cancer-fighting virus to patients undergo more PR

Introducing Gut Science - a Fundamental and Discovery Science Companion Journal to Gut (10)
LONDON, England, Nov. 10 -- The British Society of Gastroenterology issued the following news: * * * Introducing Gut Science - a fundamental and discovery science companion journal to Gut We are excited to announce a new journal from BMJ Group and the British Society of Gastroenterology - Gut Science. The launch of a new scientific journal is an auspicious moment, all the more so when it will sit alongside one of the world's leading specialty journals. For 65 years, Gut has provided cutting- more PR

Investigational daily pill lowered bad cholesterol as much as injectables (10)
DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release: * * * Investigational daily pill lowered bad cholesterol as much as injectables * Research Highlights: * For people who have experienced a heart attack or stroke, or who are at high risk of one and need further cholesterol lowering, a new daily pill may be a more convenient yet similarly effective option to injectable therapies. * The oral medication, enlicitide, lowered L more PR

Mass General Brigham Researchers Find PCSK9 Inhibitor Reduced Risk of First Heart Attack, Stroke (10)
BOSTON, Massachusetts, Nov. 8 [Category: BizHospital] -- Mass General Brigham issued the following news release: * * * Mass General Brigham Researchers Find PCSK9 Inhibitor Reduced Risk of First Heart Attack, Stroke * In a clinical trial of 12,257 patients at high risk, investigators found that adding the drug evolocumab to a patient's treatment reduced the risk of a first heart attack, first stroke, or coronary heart disease death by 25%. Researchers from Mass General Brigham have unveile more PR

Medication still better than procedure for some irregular heartbeat conditions (10)
DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release: * * * Medication still better than procedure for some irregular heartbeat conditions * Research Highlights: * Standard care, which included medication for those eligible, was better than a promising minimally invasive procedure for people with irregular heart rhythms who had high stroke and bleeding risk. * The procedure seals off a small pouch of heart tissue, where most  more PR

New medication reduced high triglyceride levels, improved cholesterol and liver health (10)
DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release: * * * New medication reduced high triglyceride levels, improved cholesterol and liver health * Research Highlights: * In a small, short-term, Phase 2 clinical trial in adults, a first-of-its-kind medication reduced triglyceride levels in most patients by more than 60%. Called DR10624, the medication activates three different receptors linked to triglycerides: FGF21, glucagon  more PR

One month of clot prevention after a stent was as effective as year-long course for AFib (10)
DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release: * * * One month of clot prevention after a stent was as effective as year-long course for AFib * Research Highlights: * A one-month course of dual clot-preventing therapy followed by a single clot-prevention medication for the remainder of the standard 12-month regimen in adults with atrial fibrillation (AFib) who received a coronary stent was as effective as one year of cont more PR

PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke (10)
DALLAS, Texas, Nov. 8 [Category: Health Care] -- The American Heart Association posted the following news release: * * * PCSK9 inhibitor reduced major CVD events in adults with no prior heart attack or stroke * Research Highlights: * Results from the international VESALIUS-CV (TIMI 66) clinical trial found that among adults with atherosclerotic cardiovascular disease (ASCVD) or diabetes and no history of a prior heart attack or stroke, the PCSK9 inhibitor evolocumab reduced the risk of co more PR

Radiotherapy After Mastectomy Can Be Avoided (10)
LONDON, England, Nov. 9 -- The National Institute for Health and Care Research issued the following news: * * * Radiotherapy after mastectomy can be avoided Women with early-stage breast cancer can avoid radiotherapy after mastectomy as it does not affect long-term survival, new research finds. An international trial found that patients with early-stage breast cancer who underwent a mastectomy (breast removal) and were taking anti-cancer drugs had similar 10-year survival rates, whether or n more PR

RPS Calls for Pharmacy Workforce Support (10)
LONDON, England, Nov. 10 -- The Royal Pharmaceutical Society issued the following news: * * * RPS calls for pharmacy workforce support The Royal Pharmaceutical Society has called for pharmacists and pharmacy to be at the heart of the forthcoming NHS workforce plan, in our response to a Government call for evidence. Following the publication of the 10 Year Health Plan in England, the Government issued a call for evidence around key factors that might influence the future NHS workforce: the 't more PR

Triglyceride-Lowering Drug Significantly Reduced Rate of Acute Pancreatitis in High-Risk Patients (10)
BOSTON, Massachusetts, Nov. 8 [Category: BizHospital] -- Mass General Brigham issued the following news release: * * * Triglyceride-Lowering Drug Significantly Reduced Rate of Acute Pancreatitis in High-Risk Patients * In two placebo-controlled clinical trials, researchers at Mass General Brigham found that olezarsen benefited those with severe hypertriglyceridemia. Researchers from Mass General Brigham have found that olezarsena drug designed to lower triglyceride levelscan also decrease  more PR

With family support, adults in rural China reduced blood pressure by average of 10 mm Hg (10)
DALLAS, Texas, Nov. 9 [Category: Health Care] -- The American Heart Association posted the following news release: * * * With family support, adults in rural China reduced blood pressure by average of 10 mm Hg * Research Highlights: * Adults in rural villages in China who participated in the Healthy Family Program, a family-based intervention that involved regular blood pressure monitoring, the use of low-sodium salt substitutes and educational sessions on healthy lifestyle habits, achiev more PR